Authors:
KRATZ R
FELICE K
GAWEL M
GELINAS D
LAI EC
LANGE DJ
NATTER HM
RUDNICKI SA
MILLER K
MURPHY MF
Citation: R. Kratz et al., EVALUATION OF THE TREATMENT EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR ON HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(2), 1996, pp. 63003-63003
Authors:
LAI EC
FELICE K
GAWEL M
GELINAS D
KRATZ R
LANGE DJ
NATTER HM
RUDNICKI SA
MILLER K
MURPHY MF
APPEL V
HAVERKAMP LJ
APPEL SH
Citation: Ec. Lai et al., AMYOTROPHIC-LATERAL-SCLEROSIS DISEASE PROGRESSION IN A HISTORICAL DATABASE GROUP ACCURATELY REFLECTS THE RATE OF DECLINE OF PLACEBO CONTROLS IN A PHASE-III CLINICAL-TRIAL FOR INSULIN-LIKE GROWTH-FACTOR, Neurology, 46(2), 1996, pp. 64003-64003
Authors:
LAI EC
FELICE K
FESTOFF BW
GAWEL M
GELINAS D
KRATZ R
LANGE DJ
MURPHY MF
NATTIER HM
RUDNICKI SA
Citation: Ec. Lai et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR LIN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(6), 1995, pp. 2-2
Authors:
MURPHY MF
FELICE K
GAWEL M
GELINAS D
KRATZ R
LAI E
LANGE D
NATTER H
RUDNICKI S
Citation: Mf. Murphy et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MYOTROPHIN (CEP-151) IN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(2), 1995, pp. 335-335